CLINICAL_TRIALS
trial_result
· 2010-08-02
Clinical Trial Update: Persistence of Rabies Antibody 1-5 Years After the Post-exposure Prophylaxis With Vero Cell Antirabies Vaccine and Antibody Response to a Single Booster Dose [Phase 4]
Summary
This Phase 4 trial update assesses how long rabies antibodies persist for 1-5 years after post-exposure prophylaxis with a Vero cell-derived rabies vaccine and …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Peking University People's Hospital | Conditions: Rabies | Phase 4 | Status: UNKNOWN